Synthetic Biology Newsletter 2.0
Posted date/time:
Science and Technology Innovation Program

This July 2011 issue of Synthetic Biology 2.0 looks at the work of the United States Presidential Bioethics Commission, the dominant discourse in the synthetic biology debate, vaccines as the first commercial applicaiton of synthetic biology, do-it-yourself biology, biosecurity, and biofiction where science and arts meet.
Author

Eleonore Pauwels
Former Global Fellow;
Formerly European Commission, Directorate-General for Research and Technological Development, Directorate on Science, Economy and Society
Formerly European Commission, Directorate-General for Research and Technological Development, Directorate on Science, Economy and Society
Science and Technology Innovation Program
The Science and Technology Innovation Program (STIP) serves as the bridge between technologists, policymakers, industry, and global stakeholders. Read more
Explore More
Browse Insights & Analysis
360° View of How Southeast Asia Can Attract More FDI in Chips and AI
Posted date/time:

The Bybit Heist: What Happened & What Now?
Posted date/time: